Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 2550Sesión 2025-2026

Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.

As Introduced

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. HB 2550›
    2. HB 2550 — As Introduced

    Kansas Legislature

    HB 2550 — As Introduced

    picture_as_pdf Download PDF Session of 2026HOUSE BILL No. 2550By Committee on InsuranceRequested by Representative Sutton1-271AN ACT concerning health and healthcare; relating to certain 340B 2entities under the federal 340B drug pricing program; requiring such 3entities to annually report to the Kansas department of insurance on 4certain costs, savings and payments made under such program; 5requiring the Kansas department of insurance to publish such reports on 6the department's website; authorizing the commissioner of insurance to 7adopt rules and regulations necessary to effectuate and administer the 8provisions of this act.910Be it enacted by the Legislature of the State of Kansas:11Section 1. As used in this act:12(a) "Department" means the Kansas department of insurance.13(b) "Commissioner" means the commissioner of insurance.14(c) "Hospital" means a hospital as defined in K.S.A. 65-450, and 15amendments thereto, that is a 340B entity. "Hospital" includes rural 16hospitals licensed under K.S.A. 65-484, and amendments thereto, that are 17340B entities.18(d) "340B contract pharmacy" means a pharmacy that has a contract 19with a 340B entity to receive and dispense 340B drugs to such 340B 20entity's patients on behalf of such 340B entity.21(e) "340B drug" means a drug that is purchased or eligible for 22purchase under section 340B of the federal public health service act, 42 23U.S.C. § 256b(a)(3), as in effect on July 1, 2026.24(f)  "340B entity" means an entity participating in the federal 340B 25drug pricing program, as described in 42 U.S.C. § 256b, as in effect on 26July 1, 2026, including such entity's pharmacy, or any pharmacy 27contracted with the participating entity to dispense drugs purchased 28through the federal 340B drug discount program.29(g) "340B program" means the federal drug pricing program under 30section 340B of the federal public health service act, 42 U.S.C. § 256b, as 31in effect on July 1, 2026.32Sec. 2. (a) On and after January 1, 2027, each hospital participating in 33the 340B program shall provide an annual report to the department. Each 34hospital shall report in a form and manner prescribed by the commissioner, 35and include, at a minimum:1(1) A description of how the hospital uses savings from participation 2in the 340B program to benefit such hospital's community through 3programs and services funded in whole or in part by savings from the 4340B program, including services that support community access to care 5that the hospital could not continue without savings from the 340B 6program; 7(2) the annual estimated savings from the 340B program to the 8hospital, comparing the acquisition price of drugs under the 340B program 9to group purchasing organization pricing. If group purchasing organization 10pricing is not available for a drug under the 340B program, the acquisition 11price for that drug shall be compared to a price from another pricing 12source, as prescribed by the commissioner;13(3) a comparison of the hospital's estimated savings under the 340B 14program to the hospital's total drug expenditures, including examples of 15the hospital's most frequently purchased drugs under the 340B program; 16and17(4) a description of the hospital's internal review and oversight of the 18340B program that satisfies the federal department of health and human 19services, health resources and services administration's program rules and 20guidance for compliance. 21 (b) (1) In addition to the requirements in subsection (a), commencing 22on January 1, 2027, each hospital shall provide an annual report to the 23department. The department shall post such report on the department's 24publicly accessible website. Each hospital shall report, in a form and 25manner prescribed by the commissioner, at a minimum, the:26(A) Hospital's national provider identification number;27(B) name of the hospital;28(C) address of the hospital for the purpose of accepting service of 29process;30(D) classification of the hospital;31(E) aggregated acquisition cost for the prescription drugs obtained 32under the 340B program;33(F) aggregated payment amount received for the prescription drugs 34obtained under the 340B program and dispensed to patients;35(G) number of pricing units dispensed or administered for 36prescription drugs described in subparagraph (F);37(H) aggregated payments made:38(i) To 340B contract pharmacies to dispense 340B drugs;39(ii) to any other entity that is not the 340B entity nor a 340B contract 40pharmacy for managing any aspect of the hospital's 340B program; and41(iii) for all other expenses related to administering the 340B program; 42and 43(I) number of claims for prescription drugs described in subparagraph 1(H).2(2)(A) The information required under this subsection shall be 3reported by payor type, as required by the commissioner. 4(B) The information required under subparagraphs (E) through (G) 5shall also be reported at the national drug code level for the 50 most 6frequently dispensed prescription drugs by the hospital under the 340B 7program. The information shall include all physician-administered and 8physician-dispensed prescription drugs.9(c) The department shall produce and post on the department's 10publicly accessible website a report that includes a summary of the 11aggregate information received from hospitals required to report under 12subsection (b). 13(d) The commissioner shall adopt all rules and regulations necessary 14to implement and administer the provisions of this act. Such rules and 15regulations shall be adopted not later than January 1, 2027.16Sec. 3. This act shall take effect and be in force from and after its 17publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 Page 3 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:41 PM 11/14/2026

    Texto oficial de la Legislatura de Kansas. El formato se adaptó para leerlo en Ratifi.